+1 (704) 266-3234

Global Swine Reproductive And Respiratory Syndrome Vaccine Market Growth 2021-2026

Published on: Jan 2021 | From USD $2900 | Published By: LP INFORMATION INC | Number Of Pages: 165

According to this latest study, the 2020 growth of Swine Reproductive and Respiratory Syndrome Vaccine will have significant change from previous year. By the most conservative estimates of global Swine Reproductive and Respiratory Syndrome Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 339.4 million in 2019. Over the next five years the Swine Reproductive and Respiratory Syndrome Vaccine market will register a 10.6% CAGR in terms of revenue, the global market size will reach US$ 507.5 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Swine Reproductive and Respiratory Syndrome Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Active Vaccine
Inactivated Vaccines
The segment of active vaccine holds a comparatively larger share in global market, which accounts for about 90%.

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Government Tender
Market Sales
The vaccine is fully applicated in market sales.

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
ASCENT CORPORATION
Boehringer-Ingelheim
MSD Animal Health
SPAH
Ceva
Chengdu TECH-BANK Biological Products Co,.Ltd
ringpu
QILU ANIMAL HEALTH PRODUCTS CO.,LTD
DAHUANONG
CAVAC
Komipharm
Agrovet
Bioveta
JINYU BIO-TECNOLOGY CO.,LTD
Phibro Animal Health
ANHUI TIANKANG(GROUP)SHRES O., LTD
Zoetis
WINSUN BIO
PULIKE BIOLOGICAL ENGINERING,INC.

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Consumption 2016-2026
2.1.2 Swine Reproductive and Respiratory Syndrome Vaccine Consumption CAGR by Region
2.2 Swine Reproductive and Respiratory Syndrome Vaccine Segment by Type
2.2.1 Active Vaccine
2.2.2 Inactivated Vaccines
2.3 Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type
2.3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2016-2021)
2.3.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue and Market Share by Type (2016-2021)
2.3.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Sale Price by Type (2016-2021)
2.4 Swine Reproductive and Respiratory Syndrome Vaccine Segment by Application
2.4.1 Government Tender
2.4.2 Market Sales
2.5 Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application
2.5.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sale Market Share by Application (2016-2021)
2.5.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue and Market Share by Application (2016-2021)
2.5.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Sale Price by Application (2016-2021)

3 Global Swine Reproductive and Respiratory Syndrome Vaccine by Company
3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Company
3.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Company (2019-2021)
3.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Company (2019-2021)
3.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Company
3.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Company (2019-2021)
3.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Company (2019-2021)
3.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Sale Price by Company
3.4 Global Manufacturers Swine Reproductive and Respiratory Syndrome Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Swine Reproductive and Respiratory Syndrome Vaccine Product Location Distribution
3.4.2 Players Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Swine Reproductive and Respiratory Syndrome Vaccine by Region
4.1 Global Swine Reproductive and Respiratory Syndrome Vaccine by Region
4.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region
4.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region
4.2 Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth
4.3 APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth
4.4 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth
4.5 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth

5 Americas
5.1 Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country
5.1.1 Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2016-2021)
5.1.2 Americas Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2016-2021)
5.2 Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type
5.3 Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region
6.1.1 APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2016-2021)
6.1.2 APAC Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (2016-2021)
6.2 APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type
6.3 APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine by Country
7.1.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2016-2021)
7.1.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2016-2021)
7.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type
7.3 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine by Country
8.1.1 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2016-2021)
8.1.2 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2016-2021)
8.2 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type
8.3 Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Swine Reproductive and Respiratory Syndrome Vaccine Distributors
10.3 Swine Reproductive and Respiratory Syndrome Vaccine Customer

11 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Forecast
11.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Forecast by Region
11.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Forecast by Regions (2021-2026)
11.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Swine Reproductive and Respiratory Syndrome Vaccine Forecast by Type
11.7 Global Swine Reproductive and Respiratory Syndrome Vaccine Forecast by Application

12 Key Players Analysis
12.1 ASCENT CORPORATION
12.1.1 ASCENT CORPORATION ASCENT CORPORATION Company Information
12.1.2 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.1.3 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 ASCENT CORPORATION Main Business Overview
12.1.5 ASCENT CORPORATION Latest Developments
12.2 Boehringer-Ingelheim
12.2.1 Boehringer-Ingelheim Company Information
12.2.2 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.2.3 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Boehringer-Ingelheim Main Business Overview
12.2.5 Boehringer-Ingelheim Latest Developments
12.3 MSD Animal Health
12.3.1 MSD Animal Health Company Information
12.3.2 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.3.3 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 MSD Animal Health Main Business Overview
12.3.5 MSD Animal Health Latest Developments
12.4 SPAH
12.4.1 SPAH Company Information
12.4.2 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.4.3 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 SPAH Main Business Overview
12.4.5 SPAH Latest Developments
12.5 Ceva
12.5.1 Ceva Company Information
12.5.2 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.5.3 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Ceva Main Business Overview
12.5.5 Ceva Latest Developments
12.6 Chengdu TECH-BANK Biological Products Co,.Ltd
12.6.1 Chengdu TECH-BANK Biological Products Co,.Ltd Company Information
12.6.2 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.6.3 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Chengdu TECH-BANK Biological Products Co,.Ltd Main Business Overview
12.6.5 Chengdu TECH-BANK Biological Products Co,.Ltd Latest Developments
12.7 ringpu
12.7.1 ringpu Company Information
12.7.2 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.7.3 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 ringpu Main Business Overview
12.7.5 ringpu Latest Developments
12.8 QILU ANIMAL HEALTH PRODUCTS CO.,LTD
12.8.1 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Company Information
12.8.2 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.8.3 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Main Business Overview
12.8.5 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Latest Developments
12.9 DAHUANONG
12.9.1 DAHUANONG Company Information
12.9.2 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.9.3 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 DAHUANONG Main Business Overview
12.9.5 DAHUANONG Latest Developments
12.10 CAVAC
12.10.1 CAVAC Company Information
12.10.2 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.10.3 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 CAVAC Main Business Overview
12.10.5 CAVAC Latest Developments
12.11 Komipharm
12.11.1 Komipharm Company Information
12.11.2 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.11.3 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Komipharm Main Business Overview
12.11.5 Komipharm Latest Developments
12.12 Agrovet
12.12.1 Agrovet Company Information
12.12.2 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.12.3 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Agrovet Main Business Overview
12.12.5 Agrovet Latest Developments
12.13 Bioveta
12.13.1 Bioveta Company Information
12.13.2 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.13.3 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Bioveta Main Business Overview
12.13.5 Bioveta Latest Developments
12.14 JINYU BIO-TECNOLOGY CO.,LTD
12.14.1 JINYU BIO-TECNOLOGY CO.,LTD Company Information
12.14.2 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.14.3 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 JINYU BIO-TECNOLOGY CO.,LTD Main Business Overview
12.14.5 JINYU BIO-TECNOLOGY CO.,LTD Latest Developments
12.15 Phibro Animal Health
12.15.1 Phibro Animal Health Company Information
12.15.2 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.15.3 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Phibro Animal Health Main Business Overview
12.15.5 Phibro Animal Health Latest Developments
12.16 ANHUI TIANKANG(GROUP)SHRES O., LTD
12.16.1 ANHUI TIANKANG(GROUP)SHRES O., LTD Company Information
12.16.2 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.16.3 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 ANHUI TIANKANG(GROUP)SHRES O., LTD Main Business Overview
12.16.5 ANHUI TIANKANG(GROUP)SHRES O., LTD Latest Developments
12.17 Zoetis
12.17.1 Zoetis Company Information
12.17.2 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.17.3 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Zoetis Main Business Overview
12.17.5 Zoetis Latest Developments
12.18 WINSUN BIO
12.18.1 WINSUN BIO Company Information
12.18.2 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.18.3 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.18.4 WINSUN BIO Main Business Overview
12.18.5 WINSUN BIO Latest Developments
12.19 PULIKE BIOLOGICAL ENGINERING,INC.
12.19.1 PULIKE BIOLOGICAL ENGINERING,INC. Company Information
12.19.2 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
12.19.3 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.19.4 PULIKE BIOLOGICAL ENGINERING,INC. Main Business Overview
12.19.5 PULIKE BIOLOGICAL ENGINERING,INC. Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Swine Reproductive and Respiratory Syndrome Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Active Vaccine
Table 3. Major Players of Inactivated Vaccines
Table 4. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2016-2021) & (K Units)
Table 5. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2016-2021)
Table 6. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2016-2021) & ($ million)
Table 7. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type (2016-2021)
Table 8. Global Swine Reproductive and Respiratory Syndrome Vaccine Sale Price by Type (2016-2021)
Table 9. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2016-2021) & (K Units)
Table 10. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2016-2021)
Table 11. Global Swine Reproductive and Respiratory Syndrome Vaccine Value by Application (2016-2021)
Table 12. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application (2016-2021)
Table 13. Global Swine Reproductive and Respiratory Syndrome Vaccine Sale Price by Application (2016-2021)
Table 14. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Company (2019-2021) & (K Units)
Table 15. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Company (2019-2021)
Table 16. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Company (2019-2021)
Table 18. Global Swine Reproductive and Respiratory Syndrome Vaccine Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Swine Reproductive and Respiratory Syndrome Vaccine Producing Area Distribution and Sales Area
Table 20. Players Swine Reproductive and Respiratory Syndrome Vaccine Products Offered
Table 21. Swine Reproductive and Respiratory Syndrome Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2016-2021) (K Units)
Table 25. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Region (2016-2021)
Table 26. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region (2016-2021)
Table 28. Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2016-2021) & (K Units)
Table 29. Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2016-2021)
Table 30. Americas Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country (2016-2021)
Table 32. Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2016-2021) & (K Units)
Table 33. Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2016-2021)
Table 34. Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2016-2021) & (K Units)
Table 35. Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2016-2021)
Table 36. APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2016-2021) & (K Units)
Table 37. APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Region (2016-2021)
Table 38. APAC Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region (2016-2021)
Table 40. APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2016-2021) & (K Units)
Table 41. APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2016-2021)
Table 42. APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2016-2021) & (K Units)
Table 43. APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2016-2021)
Table 44. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2016-2021) & (K Units)
Table 45. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2016-2021)
Table 46. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country (2016-2021)
Table 48. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2016-2021) & (K Units)
Table 49. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2016-2021)
Table 50. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2016-2021) & (K Units)
Table 51. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2016-2021)
Table 60. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Type (2021-2026) & (K Units)
Table 61. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 62. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 63. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share Forecast by Type (2021-2026)
Table 64. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Forecast by Application (2021-2026) & (K Units)
Table 65. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share Forecast by Application (2021-2026)
Table 66. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 67. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share Forecast by Application (2021-2026)
Table 68. ASCENT CORPORATION Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 69. ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 70. ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 71. ASCENT CORPORATION Main Business
Table 72. ASCENT CORPORATION Latest Developments
Table 73. Boehringer-Ingelheim Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 75. Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 76. Boehringer-Ingelheim Main Business
Table 77. Boehringer-Ingelheim Latest Developments
Table 78. MSD Animal Health Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 80. MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 81. MSD Animal Health Main Business
Table 82. MSD Animal Health Latest Developments
Table 83. SPAH Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. SPAH Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 85. SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 86. SPAH Main Business
Table 87. SPAH Latest Developments
Table 88. Ceva Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Ceva Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 90. Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 91. Ceva Main Business
Table 92. Ceva Latest Developments
Table 93. Chengdu TECH-BANK Biological Products Co,.Ltd Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 95. Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 96. Chengdu TECH-BANK Biological Products Co,.Ltd Main Business
Table 97. Chengdu TECH-BANK Biological Products Co,.Ltd Latest Developments
Table 98. ringpu Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. ringpu Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 100. ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 101. ringpu Main Business
Table 102. ringpu Latest Developments
Table 103. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 105. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 106. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Main Business
Table 107. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Latest Developments
Table 108. DAHUANONG Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 110. DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 111. DAHUANONG Main Business
Table 112. DAHUANONG Latest Developments
Table 113. CAVAC Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 115. CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 116. CAVAC Main Business
Table 117. CAVAC Latest Developments
Table 118. Komipharm Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 120. Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 121. Komipharm Main Business
Table 122. Komipharm Latest Developments
Table 123. Agrovet Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 125. Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 126. Agrovet Main Business
Table 127. Agrovet Latest Developments
Table 128. Bioveta Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 130. Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 131. Bioveta Main Business
Table 132. Bioveta Latest Developments
Table 133. JINYU BIO-TECNOLOGY CO.,LTD Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 135. JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 136. JINYU BIO-TECNOLOGY CO.,LTD Main Business
Table 137. JINYU BIO-TECNOLOGY CO.,LTD Latest Developments
Table 138. Phibro Animal Health Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 139. Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 140. Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 141. Phibro Animal Health Main Business
Table 142. Phibro Animal Health Latest Developments
Table 143. ANHUI TIANKANG(GROUP)SHRES O., LTD Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 144. ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 145. ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 146. ANHUI TIANKANG(GROUP)SHRES O., LTD Main Business
Table 147. ANHUI TIANKANG(GROUP)SHRES O., LTD Latest Developments
Table 148. Zoetis Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 149. Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 150. Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 151. Zoetis Main Business
Table 152. Zoetis Latest Developments
Table 153. WINSUN BIO Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 154. WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 155. WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 156. WINSUN BIO Main Business
Table 157. WINSUN BIO Latest Developments
Table 158. PULIKE BIOLOGICAL ENGINERING,INC. Basic Information, Swine Reproductive and Respiratory Syndrome Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 159. PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Product Offered
Table 160. PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 161. PULIKE BIOLOGICAL ENGINERING,INC. Main Business
Table 162. PULIKE BIOLOGICAL ENGINERING,INC. Latest Developments
List of Figures
Figure 1. Picture of Swine Reproductive and Respiratory Syndrome Vaccine
Figure 2. Swine Reproductive and Respiratory Syndrome Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Active Vaccine
Figure 10. Product Picture of Inactivated Vaccines
Figure 11. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type in 2020
Figure 12. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type (2016-2021)
Figure 13. Swine Reproductive and Respiratory Syndrome Vaccine Consumed in Government Tender
Figure 14. Global Swine Reproductive and Respiratory Syndrome Vaccine Market: Government Tender (2016-2021) & (K Units)
Figure 15. Swine Reproductive and Respiratory Syndrome Vaccine Consumed in Market Sales
Figure 16. Global Swine Reproductive and Respiratory Syndrome Vaccine Market: Market Sales (2016-2021) & (K Units)
Figure 17. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2016-2021)
Figure 18. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application in 2020
Figure 19. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market by Company in 2020 ($ Million)
Figure 20. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Company in 2020
Figure 21. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Regions (2016-2021)
Figure 22. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region in 2020
Figure 23. Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales 2016-2021 (K Units)
Figure 24. Americas Swine Reproductive and Respiratory Syndrome Vaccine Revenue 2016-2021 ($ Millions)
Figure 25. APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales 2016-2021 (K Units)
Figure 26. APAC Swine Reproductive and Respiratory Syndrome Vaccine Revenue 2016-2021 ($ Millions)
Figure 27. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales 2016-2021 (K Units)
Figure 28. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue 2016-2021 ($ Millions)
Figure 29. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales 2016-2021 (K Units)
Figure 30. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue 2016-2021 ($ Millions)
Figure 31. Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country in 2020
Figure 32. Americas Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country in 2020
Figure 33. Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type in 2020
Figure 34. Americas Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application in 2020
Figure 35. United States Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 36. Canada Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 37. Mexico Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 38. Brazil Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 39. APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Region in 2020
Figure 40. APAC Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Regions in 2020
Figure 41. APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type in 2020
Figure 42. APAC Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application in 2020
Figure 43. China Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 44. Japan Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 45. Korea Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 46. Southeast Asia Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 47. India Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 48. Australia Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 49. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country in 2020
Figure 50. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country in 2020
Figure 51. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type in 2020
Figure 52. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application in 2020
Figure 53. Germany Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 54. France Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 55. UK Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 56. Italy Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 57. Russia Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 58. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country in 2020
Figure 59. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country in 2020
Figure 60. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type in 2020
Figure 61. Middle East & Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application in 2020
Figure 62. Egypt Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 63. South Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 64. Israel Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 65. Turkey Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 66. GCC Country Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2900
USD $3900
USD $4900
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.